Condensed Consolidated Interim Balance Sheet as at September 30, 2020 | | | Notes | Sep. 30, 2020 | | Dec. 31, 2019 | | | EGP Thousands | | EGP Thousands | | Assets | | | | | | Cash and balances at the central bank | 7 | 35,786,423 | | 28,273,962 | | Due from banks | 8 | 56,903,819 | | 28,353,366 | | Loans and advances to banks, net | 10 | 19,021 | | 625,264 | | Loans and advances to customers, net | 11 | 119,145,984 | | 119,321,103 | | Derivative financial instruments | | 242,694 | | 216,383 | | Investments | | | | | | - Financial Assets at Fair value through P&L | 12 | 344,219 | | 418,781 | | - Financial Assets at Fair value through OCI | 12 | 119,938,583 | | 89,897,257 | | - Amortized cost | 12 | 69,896,376 | | 107,225,613 | | - Investments in associates | 13 | 141,772 | | 107,693 | | Other assets | | 9,398,676 | | 9,748,143 | | Goodwill | 0 | 223,328 | | - | | Deferred tax assets (Liabilities) | | 413,720 | | 350,339 | | Property, plant and equipment | 14 | 2,265,502 | | 2,204,464 | | Total assets | | 414,720,117 | | 386,742,368 | | Liabilities and equity | | | | | | Liabilities | | | | | | Due to banks | 15 | 8,820,095 | | 11,810,607 | | Due to customers | 16 | 332,326,819 | | 304,448,455 | | Derivative financial instruments | | 305,164 | | 282,588 | | Current tax liabilities | | 1,359,201 | | 4,639,364 | | Other liabilities | | 6,656,244 | | 8,396,794 | | Other loans | | 7,764,995 | | 3,272,746 | | Provisions | 17 | 2,960,720 | | 2,011,369 | | Total liabilities | | 360,193,238 | | 334,861,923 | | Equity | | | | | | Issued and paid up capital | | 14,776,813 | | 14,690,821 | | Reserves | | 30,496,156 | | 24,344,815 | | Reserve for employee stock ownership plan (ESOP) | | 1,410,846 | | 963,152 | | Retained earnings * | | 7,501,210 | | 11,881,657 | | Total equity | | 54,185,025 | | 51,880,445 | | Minority interest | | 341,854 | | - | | Total minority interest, equity and net profit for the period/year | 54,526,879 | | 51,880,445 | | Total liabilities and equity | | 414,720,117 | | 386,742,368 | | | | | | | | | | | | | | The accompanying notes are an integral part of these financial statements . | | | | | | (Review report attached) | | | | | * | Including net profit for the current period | | | | | | | | | | | | | | | | | | Hussein Abaza | Sherif Samy | | CEO & Board member | | Chairman | |
| | | | | | | |
| | | | | | | |
Condensed Consolidated Interim statement of other Comprehensive Income for the period ended September 30, 2020 | | | | Last 9 Months | | Last 9 Months | | | | | | | Sep. 30, 2020 | | Sep. 30, 2019 | | | | | | | EGP Thousands | | EGP Thousands | | | | | | | | | | | | | Net profit for the period | | | 7,344,292 | | 8,537,594 | | | | | | | | | | | | | Net change in fair value of instruments measured at fair value through other comprehensive income | | | (2,292,039) | | 5,271,372 | | | | Transferred from reserve for financial assets at fair value through OCI | | | (76,717) | | - | | | | Cumulative foreign currencies translation differences | | | 1,314 | | 3,747 | | | | Expected credit loss for fair value of debt instruments measured at fair value through other comprehensive income | | | 88,192 | | (71,846) | | | | Total other comprehensive income for the period | | | 5,065,042 | | 13,740,867 | | | | | | | | | | | | | As follows: | | | | | | | | | Bank's shareholders | | | 5,067,142 | | 13,740,867 | | | | Minority interest | | | (2,100) | | - | | | | Total other comprehensive income for the period | | | 5,065,042 | | 13,740,867 | | | |
| | | | | | | |
| | | | | | | | | | | Condensed Consolidated Interim Cash flows for the period ended September 30, 2020 | | | | | | | Notes | Sep. 30, 2020 | | Sep. 30, 2019 | | | EGP Thousands | | EGP Thousands | | | | | | Cash flow from operating activities | | | | | Profit before income tax from continued operations | | 11,239,451 | | 11,773,726 | Adjustments to reconcile net profit to net cash provided by operating activities | | | | | Fixed assets depreciation | 14 | 558,536 | | 425,637 | Impairment charge for credit losses (Loans and advances to customers and banks) | | 3,761,456 | | 1,256,000 | Other provisions charges | 17 | 974,522 | | 12,494 | Impairment charge for credit losses (due from banks) | | 13,218 | | 23,161 | Impairment charge for credit losses (financial investments) | | 88,192 | | (71,846) | Impairment charge for other assets | | 56,245 | | 83,213 | Exchange revaluation differences for financial assets at fair value through OCI | | 238,906 | | 1,303,741 | Goodwill amortization | 22 | 20,302 | | - | Intangible assets amortization | | - | | 97,656 | Impairment charge financial assets at fair value through OCI | | 79,126 | | 45,664 | Utilization of other provisions | 17 | (1,479) | | (27,733) | Other provisions no longer used | 17 | (6,022) | | (96,499) | Exchange differences of other provisions | 17 | (17,670) | | (103,531) | Profits from selling property, plant and equipment | | (872) | | (1,439) | (Profits) losses from selling financial investments | 12 | (979,144) | | (310,329) | Released (Impairment) charges of investments in associates and subsidiaries | | 14,100 | | - | Shares based payments | | 447,694 | | 371,997 | Bank's share in the profits of associates | | (24,327) | | (291) | Operating profits before changes in operating assets and liabilities | | 16,462,234 | | 14,781,621 | | | | | | Net decrease (increase) in assets and liabilities | | | | | Due from banks | | (5,972,551) | | (13,052,086) | Treasury bills and other governmental notes | | (4,492,317) | | 4,974,205 | Financial assets at fair value through P&L | 12 | 74,562 | | 2,252,280 | Derivative financial instruments | | (3,735) | | (67,282) | Loans and advances to banks and customers | 10 - 11 | (2,977,814) | | (4,796,325) | Other assets | | 592,680 | | 247,459 | Due to banks | 15 | (2,990,512) | | (5,431,711) | Due to customers | 16 | 27,878,364 | | 22,548,279 | Income tax obligations paid | | (4,389,254) | | (3,625,579) | Other liabilities | | (4,589,999) | | 1,862,821 | Net cash used in (generated from) operating activities | | 19,591,658 | | 19,693,682 | | | | | | Cash flow from investing activities | | | | | Proceeds from Investments in associates. | | 750 | | - | Payment for purchases of property, plant, equipment and branches constructions | | (921,312) | | (1,067,918) | Proceeds from selling property, plant and equipment | | 872 | | 1,439 | Proceeds from redemption of financial assets at amortized cost | | 37,493,345 | | 33,937,957 | Payment for purchases of financial assets at amortized cost | | - | | (47,344,534) | Payment for purchases of financial assets at fair value through OCI | | (51,331,273) | | (26,637,577) | Proceeds from selling financial assets at fair value through OCI | | 24,041,845 | | 5,350,754 | Proceeds from investment in subsidiaries. | | 194,722 | | - | Net cash generated from (used in) investing activities | | 9,478,949 | | (35,759,879) | | | | | | | | | | | | | | | | Cash flow from financing activities | | | | | Increase (decrease) in long term loans | | 4,492,249 | | (321,235) | Dividend paid | | (3,370,464) | | (2,700,544) | Capital increase | | 85,992 | | - | Net cash generated from (used in) financing activities | | 1,207,777 | | (3,021,779) | | | | | | | | | | | Net increase (decrease) in cash and cash equivalent during the period | | 30,278,384 | | (19,083,872) | Beginning balance of cash and cash equivalent | | 22,895,017 | | 34,303,645 | Cash and cash equivalent at the end of the period | | 53,173,401 | | 15,219,773 | | | | | | Cash and cash equivalent comprise: | | | | | Cash and balances at the central bank | 7 | 35,786,423 | | 27,205,020 | Due from banks | | 56,934,238 | | 25,629,602 | Treasury bills and other governmental notes | 9 | 32,133,958 | | 44,736,504 | Obligatory reserve balance with CBE | 7 | (30,004,955) | | (20,770,245) | Due from banks with maturities more than three months | | (8,958,909) | | (16,541,989) | Treasury bills with maturity more than three months | | (32,717,354) | | (45,039,119) | Total cash and cash equivalent | | 53,173,401 | | 15,219,773 |
| | | | | | | | | | | | | | | | | | |
| | | | | | | |
Condensed Consolidated Interim statement of changes in shareholders' equity for the period ended September 30, 2019 | | | | Sep. 30, 2019 | Issued and paid up capital | Legal reserve | General reserve | General risk reserve | Capital reserve | Reserve for financial assets at fair value through OCI | Banking risks reserve | Retained earnings | Reserve for employee stock ownership plan | Cumulative foreign currencies translation differences | Total Shareholders Equity | Minority Interest | Total | | | | | | | | | | | | | | | | EGP Thousands | | | Beginning balance | 11,668,326 | 1,710,293 | 12,776,215 | 1,549,445 | 12,421 | (1,860,851) | 4,323 | 9,637,083 | 738,320 | - | 36,235,575 | - | 36,235,575 | | | Capital increase | 2,917,082 | - | (2,917,082) | - | - | - | - | - | - | - | - | - | - | | | Transferred to reserves | - | 477,736 | 6,375,589 | - | 1,045 | - | - | (6,854,370) | - | - | - | - | - | | | Dividend paid | - | - | - | - | - | - | - | (2,700,544) | - | - | (2,700,544) | - | (2,700,544) | | | Net profit of the period | - | - | - | - | - | - | - | 8,537,594 | - | - | 8,537,594 | - | 8,537,594 | | | Net unrealised gain/(loss) on financial assets at fair value through OCI | - | - | - | - | - | 5,271,372 | - | - | - | - | 5,271,372 | - | 5,271,372 | | | Transferred (from) to bank risk reserve | - | - | - | - | - | - | 841 | (841) | - | - | - | - | - | | | ECL for impairment of debt instruments investments | - | - | - | - | - | (71,846) | - | - | - | - | (71,846) | - | (71,846) | | | Cost of employees stock ownership plan (ESOP) | - | - | - | - | - | - | - | - | 371,997 | - | 371,997 | - | 371,997 | | | Cumulative foreign currencies translation differences | - | - | - | - | - | - | - | - | - | 3,747 | 3,747 | - | 3,747 | | | Balance at the end of the period | 14,585,408 | 2,188,029 | 16,234,722 | 1,549,445 | 13,466 | 3,338,675 | 5,164 | 8,618,922 | 1,110,317 | 3,747 | 47,647,895 | - | 47,647,895 | | | | | | | | | | | | | | | | | | |
| | | | | | | |